VAGELOS P ROY 4
4 · REGENERON PHARMACEUTICALS, INC. · Filed Dec 20, 2021
Insider Transaction Report
Form 4
VAGELOS P ROY
Director
Transactions
- Discretionary Transaction
Common Stock
2021-12-16$634.70/sh−19$12,059→ 2,202 total(indirect: By 401(k)) - Discretionary Transaction
Common Stock
2021-12-16$635.03/sh−107$67,948→ 2,095 total(indirect: By 401(k))
Holdings
- 141,630(indirect: by CLAT)
Common Stock
- 37,747(indirect: By Trust)
Common Stock
- 3,609(indirect: By Trust)
Common Stock
- 318,669
Common Stock
Footnotes (2)
- [F1]Represents volume-weighted average price of sales of 107 shares of Company stock on December 16, 2021 at prices ranging from $635.00 to $635.06. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 16, 2021 at each separate price.
- [F2]By trusts for the benefit of nine grandchildren of the reporting person, each of which holds 401 shares of Company stock. The reporting person and/or the spouse of the reporting person is the trustee of each such trust.